{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T21:13:10Z","timestamp":1735765990591,"version":"3.32.0"},"reference-count":42,"publisher":"Informa UK Limited","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2002,11]]},"DOI":"10.1517\/13543784.11.11.1633","type":"journal-article","created":{"date-parts":[[2005,5,4]],"date-time":"2005-05-04T20:20:28Z","timestamp":1115238028000},"page":"1633-1643","source":"Crossref","is-referenced-by-count":0,"title":["Ongoing trials involving angiotensin-converting enzyme inhibitors"],"prefix":"10.1517","volume":"11","author":[{"given":"Sunil","family":"Nadar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory YH","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2005,2,24]]},"reference":[{"doi-asserted-by":"publisher","key":"CIT0001","DOI":"10.1161\/01.RES.87.5.e1"},{"issue":"43","key":"CIT0002","first-page":"33238","volume":"275","author":"TIPNIS SR","year":"2000","journal-title":"Cloning and functional expression as a captopril-insensitive carboxypeptidase. Biol. Chem."},{"doi-asserted-by":"publisher","key":"CIT0003","DOI":"10.1038\/nature00786"},{"issue":"205","key":"CIT0004","first-page":"S\u2013213S","volume":"12","author":"WEIR MR","year":"1999","journal-title":"Am. Hyperten."},{"doi-asserted-by":"publisher","key":"CIT0006","DOI":"10.1016\/0002-9149(84)90692-1"},{"doi-asserted-by":"publisher","key":"CIT0007","DOI":"10.1016\/0002-9149(84)90634-9"},{"key":"CIT0008","first-page":"789","volume":"37","author":"GAUDIO C","year":"1992","journal-title":"Cardiologia"},{"doi-asserted-by":"publisher","key":"CIT0009","DOI":"10.1001\/jama.1996.03530430051039"},{"issue":"7","key":"CIT0010","first-page":"5157","volume":"10","author":"SCHALEKAMP MA","year":"1992","journal-title":"J. Hypertens. Sapp]."},{"issue":"4","key":"CIT0013","first-page":"1731","volume":"90","author":"RUTHERFORD JD","year":"1994","journal-title":"Results of the Survival and Ventricular Enlargement trial. SAVE Investigators. Circulation"},{"doi-asserted-by":"publisher","key":"CIT0014","DOI":"10.1056\/NEJM198706043162301"},{"doi-asserted-by":"publisher","key":"CIT0015","DOI":"10.1056\/NEJM199108013250501"},{"issue":"7","key":"CIT0016","first-page":"665","volume":"12","author":"BORGHI C","year":"1999","journal-title":"SMILE Study Investigators. Survival of Myocardial Infarction Long-term Evaluation. Am. J. Hypertens."},{"issue":"2","key":"CIT0017","first-page":"80","volume":"332","author":"AMBROSIONI E","year":"1995","journal-title":"The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators. N Engl. J. Med."},{"doi-asserted-by":"publisher","key":"CIT0018","DOI":"10.1053\/euhj.1997.0822"},{"doi-asserted-by":"publisher","key":"CIT0019","DOI":"10.1161\/01.CIR.96.12.4239"},{"issue":"9064","key":"CIT0021","first-page":"1493","volume":"349","author":"HALL AS","year":"1997","journal-title":"Acute Infarction Ramipril Efficacy. Lancet"},{"issue":"1","key":"CIT0022","first-page":"41","volume":"18","author":"CLELAND JG","year":"1997","journal-title":"A report from the AIRE Study Investigators. Ear: Heart J."},{"issue":"8875","key":"CIT0023","first-page":"821","volume":"342","author":"AIRE STUDY INVESTIGATORS","year":"1993","journal-title":"Lancet"},{"doi-asserted-by":"publisher","key":"CIT0024","DOI":"10.1056\/NEJM199209033271001"},{"doi-asserted-by":"publisher","key":"CIT0025","DOI":"10.1016\/0140-6736(92)92889-N"},{"doi-asserted-by":"publisher","key":"CIT0026","DOI":"10.1093\/cvr\/28.2.159"},{"issue":"3","key":"CIT0029","first-page":"145","volume":"342","author":"YUSUF S","year":"2000","journal-title":"The Heart Outcomes Prevention Evaluation Study Investigators. N Engl. J. Med"},{"doi-asserted-by":"publisher","key":"CIT0030","DOI":"10.1161\/01.CIR.94.3.258"},{"doi-asserted-by":"publisher","key":"CIT0031","DOI":"10.1016\/S0140-6736(01)06178-5"},{"doi-asserted-by":"publisher","key":"CIT0032","DOI":"10.1001\/archinte.1996.00440030080010"},{"doi-asserted-by":"publisher","key":"CIT0033","DOI":"10.1056\/NEJM199604113341502"},{"doi-asserted-by":"publisher","key":"CIT0034","DOI":"10.1056\/NEJM199311113292004"},{"doi-asserted-by":"publisher","key":"CIT0035","DOI":"10.2337\/diab.46.7.1182"},{"issue":"1","key":"CIT0038","first-page":"527\u2013S30","volume":"15","author":"NIEMINEN MS","year":"2001","journal-title":"Hum. Hypertens."},{"issue":"1","key":"CIT0039","first-page":"S35\u2013S38","volume":"15","author":"JULKUNEN J","year":"2001","journal-title":"J. Hum. Hypertens."},{"key":"CIT0040","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/sj.jhh.1001236","volume":"15","author":"SPENCER CGC, BEEVERS DG, LIP GY","year":"2001","journal-title":"\" Hum. Hypertens."},{"doi-asserted-by":"publisher","key":"CIT0041","DOI":"10.2165\/00002512-200118030-00001"},{"issue":"5","key":"CIT0043","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3109\/10641969709083186","volume":"19","author":"WING LM","year":"1997","journal-title":"Australian Comparative Outcome Trial of ACE inhib. Clin. Exp. Hypertens."},{"doi-asserted-by":"publisher","key":"CIT0044","DOI":"10.1161\/01.HYP.37.1.19"},{"issue":"15","key":"CIT0046","first-page":"1967","volume":"283","author":"Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone","year":"2000","journal-title":"ALLHAT Collaborative Research GROUP \"AMA"},{"doi-asserted-by":"publisher","key":"CIT0047","DOI":"10.1016\/S0895-7061(02)02996-5"},{"issue":"8","key":"CIT0050","first-page":"718","volume":"57","author":"MILLER JL","year":"2000","journal-title":"Am. I. Health Syst. Pharm."},{"doi-asserted-by":"publisher","key":"CIT0054","DOI":"10.1023\/A:1011131130922"},{"doi-asserted-by":"publisher","key":"CIT0058","DOI":"10.1016\/S0197-2456(00)00060-X"},{"doi-asserted-by":"publisher","key":"CIT0060","DOI":"10.1016\/S0140-6736(02)09895-1"},{"doi-asserted-by":"publisher","key":"CIT0061","DOI":"10.1067\/mhj.2000.108832"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/13543784.11.11.1633","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T03:12:37Z","timestamp":1735701157000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/13543784.11.11.1633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11]]},"references-count":42,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2005,2,24]]},"published-print":{"date-parts":[[2002,11]]}},"alternative-id":["10.1517\/13543784.11.11.1633"],"URL":"https:\/\/doi.org\/10.1517\/13543784.11.11.1633","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"type":"print","value":"1354-3784"},{"type":"electronic","value":"1744-7658"}],"subject":[],"published":{"date-parts":[[2002,11]]}}}